article thumbnail

Amvia Sky Launched in Canada, the World’s First Pacemaker Approved for LBBAP

DAIC

Fadi Mansour performed the first Canadian implant of BIOTRONIK ’s newest pacemaker and CRT-P generation earlier this year at the Centre Hospitalier de l'Université de Montréal. The patient received an Amvia Sky HF-T QP triple chamber pacemaker device. Enhanced Closed Loop Stimulation (CLS) rate adaptation technology.

Pacemaker 105
article thumbnail

UC San Diego Health First in Region to Implant Dual Chamber, Leadless Pacemaker

DAIC

UC San Diego Health is the first in San Diego to successfully implant the world’s first dual chamber and leadless pacemaker system to help treat people with abnormal heart rhythms. Holding the device and pictured above is Ulrika Birgersdotter-Green, MD, cardiologist and director of pacemaker and ICD services at UC San Diego Health.

Pacemaker 105
article thumbnail

Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients

DAIC

milla1cf Fri, 01/19/2024 - 10:55 January 19, 2024 — Orchestra BioMed , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the first patient was randomized in the BACKBEAT pivotal study in late December 2023. Orchestra BioMed and Medtronic, Inc.

Pacemaker 105
article thumbnail

DAIC's Top 10 for June

DAIC

Landmark Clinical Study in The Lancet Finds New AI Technology Can Predict Cardiac Events Due to Coronary Inflammation at Least 10 Years in Advance 3. HonorHealth Research Institute Study Uses New Programing for Pacemakers to Control High Blood Pressure Without Additional Drugs 6.

article thumbnail

Vivasure Medical Announces First Large Hole Venous Patient Treated with PerQseal Elite Vascular Closure System

DAIC

milla1cf Tue, 04/16/2024 - 12:40 April 16, 2024 — Vivasure Medical , a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced it has treated the first large bore venous patient with the PerQseal Elite vascular closure system, a sutureless and fully bioresorbable large-bore vessel closure device.

article thumbnail

Emerging pacemaker technology for small children

HeartRhythm

Devices and implantation techniques are primarily designed for the adult population. Pediatric electrophysiologists continue to find creative solutions to adapt adult-sized equipment into vulnerable pediatric patients.

article thumbnail

Heart rhythm in vitro: measuring stem cell-derived pacemaker cells on microelectrode arrays

Frontiers in Cardiovascular Medicine

However, there is currently no commercially available cell source to apply this technology in the context of the cardiac conduction system (CCS). In response to this problem, our group has previously developed a protocol for the generation of pure functional cardiac pacemaker cells from mouse embryonic stem cells (ESCs).